When Less Is Good, Is None Better? The Prognostic and Therapeutic Significance of Peri-Transplant Minimal Residual Disease Assessment in Pediatric Acute Lymphoblastic Leukemia-Reference-Cited by-同舟云学术

When Less Is Good, Is None Better? The Prognostic and Therapeutic Significance of Peri-Transplant Minimal Residual Disease Assessment in Pediatric Acute Lymphoblastic Leukemia

Published:2017-07-07 Issue:7 Volume:6 Page:66
ISSN:2077-0383
Container-title:Journal of Clinical Medicine
language:en
Short-container-title:JCM

Author:

Lamble Adam,Phelan Rachel,Burke Michael

Publisher

MDPI AG

Subject

General Medicine

Link

http://www.mdpi.com/2077-0383/6/7/66/pdf

Reference85 articles.

1. Children's Oncology Group's 2013 blueprint for research: acute lymphoblastic leukemia

2. Improved outcomes with allogeneic hematopoietic cell transplantation

3. Twenty Years of Unrelated Donor Bone Marrow Transplantation for Pediatric Acute Leukemia Facilitated by the National Marrow Donor Program

4. Relapse after Allogeneic Hematopoietic Cell Therapy

5. Role of Cytotoxic Therapy with Hematopoietic Stem Cell Transplantation in the Treatment of Pediatric Acute Lymphoblastic Leukemia: Update of the 2005 Evidence-Based Review

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Disease Status and Interval between Hematopoietic Cell Transplantations Predict Outcome of Pediatric Patients Who Undergo Subsequent Transplantation for Relapsed Hematologic Malignancy;Transplantation and Cellular Therapy;2024-05

2. Blinatumomab Therapy Is Associated with Favorable Outcomes after Allogeneic Hematopoietic Cell Transplantation in Pediatric Patients with B Cell Acute Lymphoblastic Leukemia;Transplantation and Cellular Therapy;2024-02

3. Highly-sensitive chimerism analysis in blood after allogeneic hematopoietic cell transplantation in childhood leukemia: Results from the Nordic Microchimerism Study;Frontiers in Hematology;2023-02-06

4. Time to transplantation and pediatric acute myeloid leukemia outcomes;Bone Marrow Transplantation;2022-12-10

5. Immunotherapy and Allogeneic Bone Marrow Transplantation in B Acute Lymphoblastic Leukemia: How to Sequence?;Clinical Hematology International;2022-05-11